10-Q
OXIGENE, INC. FORM 10-Q
- Company
- Oncotelic Therapeutics, Inc.
- Filed
- August 7, 2007
- Period of Report
- June 30, 2007
- Accession Number
- 0000950135-07-004775
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →